Cargando…
Recent Advances in Methods for Circulating Tumor Cell Detection
Circulating tumor cells (CTCs) are released from primary tumors and transported through the body via blood or lymphatic vessels before settling to form micrometastases under suitable conditions. Accordingly, several studies have identified CTCs as a negative prognostic factor for survival in many ty...
Autores principales: | Vidlarova, Monika, Rehulkova, Alona, Stejskal, Pavel, Prokopova, Andrea, Slavik, Hanus, Hajduch, Marian, Srovnal, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959336/ https://www.ncbi.nlm.nih.gov/pubmed/36835311 http://dx.doi.org/10.3390/ijms24043902 |
Ejemplares similares
-
Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling
por: Slavik, Hanus, et al.
Publicado: (2020) -
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
por: Rehulkova, Alona, et al.
Publicado: (2023) -
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
por: Vidlarova, Monika, et al.
Publicado: (2022) -
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence
por: Slavik, Hanus, et al.
Publicado: (2022) -
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
por: Stejskal, Pavel, et al.
Publicado: (2023)